Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 40 entries
Sorted by: Best Match Show Resources per page
Enriched biodiversity data as a resource and service.

Biodiversity data journal

Vos RA, Biserkov JV, Balech B, Beard N, Blissett M, Brenninkmeijer C, van Dooren T, Eades D, Gosline G, Groom QJ, Hamann TD, Hettling H, Hoehndorf R, Holleman A, Hovenkamp P, Kelbert P, King D, Kirkup D, Lammers Y, DeMeulemeester T, Mietchen D, Miller JA, Mounce R, Nicolson N, Page R, Pawlik A, Pereira S, Penev L, Richards K, Sautter G, Shorthouse DP, Tähtinen M, Weiland C, Williams AR, Sierra S.
PMID: 25057255
Biodivers Data J. 2014 Jun 16;(2):e1125. doi: 10.3897/BDJ.2.e1125. eCollection 2014.

BACKGROUND: Recent years have seen a surge in projects that produce large volumes of structured, machine-readable biodiversity data. To make these data amenable to processing by generic, open source "data enrichment" workflows, they are increasingly being represented in a...

Cite
Vos RA, Biserkov JV, Balech B, et al. Enriched biodiversity data as a resource and service. Biodivers Data J. 2014;(2):e1125doi: 10.3897/BDJ.2.e1125.
Vos, R. A., Biserkov, J. V., Balech, B., Beard, N., Blissett, M., Brenninkmeijer, C., van Dooren, T., Eades, D., Gosline, G., Groom, Q. J., Hamann, T. D., Hettling, H., Hoehndorf, R., Holleman, A., Hovenkamp, P., Kelbert, P., King, D., Kirkup, D., Lammers, Y., DeMeulemeester, T., Mietchen, D., Miller, J. A., Mounce, R., Nicolson, N., Page, R., Pawlik, A., Pereira, S., Penev, L., Richards, K., Sautter, G., Shorthouse, D. P., Tähtinen, M., Weiland, C., Williams, A. R., & Sierra, S. (2014). Enriched biodiversity data as a resource and service. Biodiversity data journal, (2), e1125. https://doi.org/10.3897/BDJ.2.e1125
Vos, Rutger Aldo, et al. "Enriched biodiversity data as a resource and service." Biodiversity data journal vol. ,2 (2014): e1125. doi: https://doi.org/10.3897/BDJ.2.e1125
Vos RA, Biserkov JV, Balech B, Beard N, Blissett M, Brenninkmeijer C, van Dooren T, Eades D, Gosline G, Groom QJ, Hamann TD, Hettling H, Hoehndorf R, Holleman A, Hovenkamp P, Kelbert P, King D, Kirkup D, Lammers Y, DeMeulemeester T, Mietchen D, Miller JA, Mounce R, Nicolson N, Page R, Pawlik A, Pereira S, Penev L, Richards K, Sautter G, Shorthouse DP, Tähtinen M, Weiland C, Williams AR, Sierra S. Enriched biodiversity data as a resource and service. Biodivers Data J. 2014 Jun 16;(2):e1125. doi: 10.3897/BDJ.2.e1125. eCollection 2014. PMID: 25057255; PMCID: PMC4092319.
Copy Download .nbib Format: NLM
A framework for extending trial design to facilitate missing data sensitivity analyses.

BMC medical research methodology

Mason AJ, Grieve RD, Richards-Belle A, Mouncey PR, Harrison DA, Carpenter JR.
PMID: 32183708
BMC Med Res Methodol. 2020 Mar 17;20(1):66. doi: 10.1186/s12874-020-00930-2.

BACKGROUND: Missing data are an inevitable challenge in Randomised Controlled Trials (RCTs), particularly those with Patient Reported Outcome Measures. Methodological guidance suggests that to avoid incorrect conclusions, studies should undertake sensitivity analyses which recognise that data may be 'missing...

Cite
Mason AJ, Grieve RD, Richards-Belle A, et al. A framework for extending trial design to facilitate missing data sensitivity analyses. BMC Med Res Methodol. 2020;20(1):66doi: 10.1186/s12874-020-00930-2.
Mason, A. J., Grieve, R. D., Richards-Belle, A., Mouncey, P. R., Harrison, D. A., & Carpenter, J. R. (2020). A framework for extending trial design to facilitate missing data sensitivity analyses. BMC medical research methodology, 20(1), 66. https://doi.org/10.1186/s12874-020-00930-2
Mason, Alexina J, et al. "A framework for extending trial design to facilitate missing data sensitivity analyses." BMC medical research methodology vol. 20,1 (2020): 66. doi: https://doi.org/10.1186/s12874-020-00930-2
Mason AJ, Grieve RD, Richards-Belle A, Mouncey PR, Harrison DA, Carpenter JR. A framework for extending trial design to facilitate missing data sensitivity analyses. BMC Med Res Methodol. 2020 Mar 17;20(1):66. doi: 10.1186/s12874-020-00930-2. PMID: 32183708; PMCID: PMC7076973.
Copy Download .nbib Format: NLM
Development of platforms for functional characterization and production of phenazines using a multi-chassis approach via CRAGE.

Metabolic engineering

Ke J, Zhao Z, Coates CR, Hadjithomas M, Kuftin A, Louie K, Weller D, Thomashow L, Mouncey NJ, Northen TR, Yoshikuni Y.
PMID: 34890798
Metab Eng. 2021 Dec 08;69:188-197. doi: 10.1016/j.ymben.2021.11.012. Epub 2021 Dec 08.

Phenazines (Phzs), a family of chemicals with a phenazine backbone, are secondary metabolites with diverse properties such as antibacterial, anti-fungal, or anticancer activity. The core derivatives of phenazine, phenazine-1-carboxylic acid (PCA) and phenazine-1,6-dicarboxylic acid (PDC), are themselves precursors for...

Cite
Ke J, Zhao Z, Coates CR, et al. Development of platforms for functional characterization and production of phenazines using a multi-chassis approach via CRAGE. Metab Eng. 2021;69:188-197doi: 10.1016/j.ymben.2021.11.012.
Ke, J., Zhao, Z., Coates, C. R., Hadjithomas, M., Kuftin, A., Louie, K., Weller, D., Thomashow, L., Mouncey, N. J., Northen, T. R., & Yoshikuni, Y. (2021). Development of platforms for functional characterization and production of phenazines using a multi-chassis approach via CRAGE. Metabolic engineering, 69188-197. https://doi.org/10.1016/j.ymben.2021.11.012
Ke, Jing, et al. "Development of platforms for functional characterization and production of phenazines using a multi-chassis approach via CRAGE." Metabolic engineering vol. 69 (2021): 188-197. doi: https://doi.org/10.1016/j.ymben.2021.11.012
Ke J, Zhao Z, Coates CR, Hadjithomas M, Kuftin A, Louie K, Weller D, Thomashow L, Mouncey NJ, Northen TR, Yoshikuni Y. Development of platforms for functional characterization and production of phenazines using a multi-chassis approach via CRAGE. Metab Eng. 2021 Dec 08;69:188-197. doi: 10.1016/j.ymben.2021.11.012. Epub 2021 Dec 08. PMID: 34890798.
Copy Download .nbib Format: NLM
Correction to: COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland.

Intensive care medicine

Richards-Belle A, Orzechowska I, Gould DW, Thomas K, Doidge JC, Mouncey PR, Christian MD, Shankar-Hari M, Harrison DA, Rowan KM.
PMID: 34061211
Intensive Care Med. 2021 Jun;47(6):731-732. doi: 10.1007/s00134-021-06413-2.

No abstract available.

Cite
Richards-Belle A, Orzechowska I, Gould DW, et al. Correction to: COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland. Intensive Care Med. 2021;47(6):731-732doi: 10.1007/s00134-021-06413-2.
Richards-Belle, A., Orzechowska, I., Gould, D. W., Thomas, K., Doidge, J. C., Mouncey, P. R., Christian, M. D., Shankar-Hari, M., Harrison, D. A., Rowan, K. M. (2021). Correction to: COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland. Intensive care medicine, 47(6), 731-732. https://doi.org/10.1007/s00134-021-06413-2
Richards-Belle, Alvin, et al. "Correction to: COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland." Intensive care medicine vol. 47,6 (2021): 731-732. doi: https://doi.org/10.1007/s00134-021-06413-2
Richards-Belle A, Orzechowska I, Gould DW, Thomas K, Doidge JC, Mouncey PR, Christian MD, Shankar-Hari M, Harrison DA, Rowan KM. Correction to: COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland. Intensive Care Med. 2021 Jun;47(6):731-732. doi: 10.1007/s00134-021-06413-2. PMID: 34061211; PMCID: PMC8167301.
Copy Download .nbib Format: NLM
Evaluating the clinical and cost-effectiveness of permissive hypotension in critically ill patients aged 65 years or over with vasodilatory hypotension: Protocol for the 65 randomised clinical trial.

Journal of the Intensive Care Society

Richards-Belle A, Mouncey PR, Grieve RD, Harrison DA, Sadique MZ, Henry D, Whitman C, Camsooksai J, Gordon AC, Young JD, Rowan KM, Lamontagne F.
PMID: 34093727
J Intensive Care Soc. 2020 Nov;21(4):281-282. doi: 10.1177/1751143720971433. Epub 2020 Dec 08.

Vasodilatory shock is common in critically ill patients and vasopressors are a mainstay of therapy. A meta-analysis suggested that use of a higher, as opposed to a lower, mean arterial pressure target to guide titration of vasopressor therapy, could...

Cite
Richards-Belle A, Mouncey PR, Grieve RD, et al. Evaluating the clinical and cost-effectiveness of permissive hypotension in critically ill patients aged 65 years or over with vasodilatory hypotension: Protocol for the 65 randomised clinical trial. J Intensive Care Soc. 2020;21(4):281-282doi: 10.1177/1751143720971433.
Richards-Belle, A., Mouncey, P. R., Grieve, R. D., Harrison, D. A., Sadique, M. Z., Henry, D., Whitman, C., Camsooksai, J., Gordon, A. C., Young, J. D., Rowan, K. M., & Lamontagne, F. (2020). Evaluating the clinical and cost-effectiveness of permissive hypotension in critically ill patients aged 65 years or over with vasodilatory hypotension: Protocol for the 65 randomised clinical trial. Journal of the Intensive Care Society, 21(4), 281-282. https://doi.org/10.1177/1751143720971433
Richards-Belle, Alvin, et al. "Evaluating the clinical and cost-effectiveness of permissive hypotension in critically ill patients aged 65 years or over with vasodilatory hypotension: Protocol for the 65 randomised clinical trial." Journal of the Intensive Care Society vol. 21,4 (2020): 281-282. doi: https://doi.org/10.1177/1751143720971433
Richards-Belle A, Mouncey PR, Grieve RD, Harrison DA, Sadique MZ, Henry D, Whitman C, Camsooksai J, Gordon AC, Young JD, Rowan KM, Lamontagne F. Evaluating the clinical and cost-effectiveness of permissive hypotension in critically ill patients aged 65 years or over with vasodilatory hypotension: Protocol for the 65 randomised clinical trial. J Intensive Care Soc. 2020 Nov;21(4):281-282. doi: 10.1177/1751143720971433. Epub 2020 Dec 08. PMID: 34093727; PMCID: PMC8142090.
Copy Download .nbib Format: NLM
Development of platforms for functional characterization and production of phenazines using a multi-chassis approach via CRAGE.

Metabolic engineering

Ke J, Zhao Z, Coates CR, Hadjithomas M, Kuftin A, Louie K, Weller D, Thomashow L, Mouncey NJ, Northen TR, Yoshikuni Y.
PMID: 34890798
Metab Eng. 2021 Dec 08;69:188-197. doi: 10.1016/j.ymben.2021.11.012. Epub 2021 Dec 08.

Phenazines (Phzs), a family of chemicals with a phenazine backbone, are secondary metabolites with diverse properties such as antibacterial, anti-fungal, or anticancer activity. The core derivatives of phenazine, phenazine-1-carboxylic acid (PCA) and phenazine-1,6-dicarboxylic acid (PDC), are themselves precursors for...

Cite
Ke J, Zhao Z, Coates CR, et al. Development of platforms for functional characterization and production of phenazines using a multi-chassis approach via CRAGE. Metab Eng. 2021;69:188-197doi: 10.1016/j.ymben.2021.11.012.
Ke, J., Zhao, Z., Coates, C. R., Hadjithomas, M., Kuftin, A., Louie, K., Weller, D., Thomashow, L., Mouncey, N. J., Northen, T. R., & Yoshikuni, Y. (2021). Development of platforms for functional characterization and production of phenazines using a multi-chassis approach via CRAGE. Metabolic engineering, 69188-197. https://doi.org/10.1016/j.ymben.2021.11.012
Ke, Jing, et al. "Development of platforms for functional characterization and production of phenazines using a multi-chassis approach via CRAGE." Metabolic engineering vol. 69 (2021): 188-197. doi: https://doi.org/10.1016/j.ymben.2021.11.012
Ke J, Zhao Z, Coates CR, Hadjithomas M, Kuftin A, Louie K, Weller D, Thomashow L, Mouncey NJ, Northen TR, Yoshikuni Y. Development of platforms for functional characterization and production of phenazines using a multi-chassis approach via CRAGE. Metab Eng. 2021 Dec 08;69:188-197. doi: 10.1016/j.ymben.2021.11.012. Epub 2021 Dec 08. PMID: 34890798.
Copy Download .nbib Format: NLM
Retrospective analysis of the population dynamics and racing outcomes of the 2014 and 2015 UK and Ireland Thoroughbred foal crops.

The Veterinary record

Arango-Sabogal JC, Mouncey R, de Mestre AM, Verheyen K.
PMID: 33870524
Vet Rec. 2021 Sep;189(5):e298. doi: 10.1002/vetr.298. Epub 2021 Apr 18.

BACKGROUND: Up-to-date figures on early losses of Thoroughbreds from the racing industry can inform strategies to improve retention and incentivise traceability of Thoroughbreds during this early life period.METHODS: Data on Thoroughbred mares bred in 2013-2014 and training, racing and...

Cite
Arango-Sabogal JC, Mouncey R, de Mestre AM, et al. Retrospective analysis of the population dynamics and racing outcomes of the 2014 and 2015 UK and Ireland Thoroughbred foal crops. Vet Rec. 2021;189(5):e298doi: 10.1002/vetr.298.
Arango-Sabogal, J. C., Mouncey, R., de Mestre, A. M., & Verheyen, K. (2021). Retrospective analysis of the population dynamics and racing outcomes of the 2014 and 2015 UK and Ireland Thoroughbred foal crops. The Veterinary record, 189(5), e298. https://doi.org/10.1002/vetr.298
Arango-Sabogal, Juan Carlos, et al. "Retrospective analysis of the population dynamics and racing outcomes of the 2014 and 2015 UK and Ireland Thoroughbred foal crops." The Veterinary record vol. 189,5 (2021): e298. doi: https://doi.org/10.1002/vetr.298
Arango-Sabogal JC, Mouncey R, de Mestre AM, Verheyen K. Retrospective analysis of the population dynamics and racing outcomes of the 2014 and 2015 UK and Ireland Thoroughbred foal crops. Vet Rec. 2021 Sep;189(5):e298. doi: 10.1002/vetr.298. Epub 2021 Apr 18. PMID: 33870524.
Copy Download .nbib Format: NLM
Author Correction: A genomic catalog of Earth's microbiomes.

Nature biotechnology

Nayfach S, Roux S, Seshadri R, Udwary D, Varghese N, Schulz F, Wu D, Paez-Espino D, Chen IM, Huntemann M, Palaniappan K, Ladau J, Mukherjee S, Reddy TBK, Nielsen T, Kirton E, Faria JP, Edirisinghe JN, Henry CS, Jungbluth SP, Chivian D, Dehal P, Wood-Charlson EM, Arkin AP, Tringe SG, Visel A, Woyke T, Mouncey NJ, Ivanova NN, Kyrpides NC, Eloe-Fadrosh EA.
PMID: 33795890
Nat Biotechnol. 2021 Apr;39(4):521. doi: 10.1038/s41587-021-00898-4.

No abstract available.

Cite
Nayfach S, Roux S, Seshadri R, et al. Author Correction: A genomic catalog of Earth's microbiomes. Nat Biotechnol. 2021;39(4):521doi: 10.1038/s41587-021-00898-4.
Nayfach, S., Roux, S., Seshadri, R., Udwary, D., Varghese, N., Schulz, F., Wu, D., Paez-Espino, D., Chen, I. M., Huntemann, M., Palaniappan, K., Ladau, J., Mukherjee, S., Reddy, T. B. K., Nielsen, T., Kirton, E., Faria, J. P., Edirisinghe, J. N., Henry, C. S., Jungbluth, S. P., Chivian, D., Dehal, P., Wood-Charlson, E. M., Arkin, A. P., Tringe, S. G., Visel, A., Woyke, T., Mouncey, N. J., Ivanova, N. N., Kyrpides, N. C., & Eloe-Fadrosh, E. A. (2021). Author Correction: A genomic catalog of Earth's microbiomes. Nature biotechnology, 39(4), 521. https://doi.org/10.1038/s41587-021-00898-4
Nayfach, Stephen, et al. "Author Correction: A genomic catalog of Earth's microbiomes." Nature biotechnology vol. 39,4 (2021): 521. doi: https://doi.org/10.1038/s41587-021-00898-4
Nayfach S, Roux S, Seshadri R, Udwary D, Varghese N, Schulz F, Wu D, Paez-Espino D, Chen IM, Huntemann M, Palaniappan K, Ladau J, Mukherjee S, Reddy TBK, Nielsen T, Kirton E, Faria JP, Edirisinghe JN, Henry CS, Jungbluth SP, Chivian D, Dehal P, Wood-Charlson EM, Arkin AP, Tringe SG, Visel A, Woyke T, Mouncey NJ, Ivanova NN, Kyrpides NC, Eloe-Fadrosh EA. Author Correction: A genomic catalog of Earth's microbiomes. Nat Biotechnol. 2021 Apr;39(4):521. doi: 10.1038/s41587-021-00898-4. PMID: 33795890; PMCID: PMC8041621.
Copy Download .nbib Format: NLM
Recent developments in scholarly publishing to improve research practices in the life sciences.

Emerging topics in life sciences

Eglen SJ, Mounce R, Gatto L, Currie AM, Nobis Y, Calvo‐Ferrer JR.
PMID: 33530668
Emerg Top Life Sci. 2018 Dec 21;2(6):775-778. doi: 10.1042/ETLS20180172.

We outline recent developments in scholarly publishing that we think will improve the working environment and career prospects for life scientists. Most prominently, we discuss two key developments. (1) Life scientists are now embracing a preprint culture leading to...

Cite
Eglen SJ, Mounce R, Gatto L, et al. Recent developments in scholarly publishing to improve research practices in the life sciences. Emerg Top Life Sci. 2018;2(6):775-778doi: 10.1042/ETLS20180172.
Eglen, S. J., Mounce, R., Gatto, L., Currie, A. M., Nobis, Y., & Calvo‐Ferrer, J. R. (2018). Recent developments in scholarly publishing to improve research practices in the life sciences. Emerging topics in life sciences, 2(6), 775-778. https://doi.org/10.1042/ETLS20180172
Eglen, Stephen J, et al. "Recent developments in scholarly publishing to improve research practices in the life sciences." Emerging topics in life sciences vol. 2,6 (2018): 775-778. doi: https://doi.org/10.1042/ETLS20180172
Eglen SJ, Mounce R, Gatto L, Currie AM, Nobis Y, Calvo‐Ferrer JR. Recent developments in scholarly publishing to improve research practices in the life sciences. Emerg Top Life Sci. 2018 Dec 21;2(6):775-778. doi: 10.1042/ETLS20180172. PMID: 33530668; PMCID: PMC7289060.
Copy Download .nbib Format: NLM
Comparative effectiveness of common treatments for new-onset atrial fibrillation within the ICU: Accounting for physiological status.

Journal of critical care

Bedford JP, Johnson A, Redfern O, Gerry S, Doidge J, Harrison D, Rajappan K, Rowan K, Young JD, Mouncey P, Watkinson PJ.
PMID: 34798373
J Crit Care. 2021 Nov 16;67:149-156. doi: 10.1016/j.jcrc.2021.11.005. Epub 2021 Nov 16.

BACKGROUND: New-onset atrial fibrillation (NOAF) is common in patients on an intensive care unit (ICU). Evidence guiding treatments is limited, though recent reports suggest beta blocker (BB) therapy is associated with reduced mortality.METHODS: We conducted a multicentre cohort study...

Cite
Bedford JP, Johnson A, Redfern O, et al. Comparative effectiveness of common treatments for new-onset atrial fibrillation within the ICU: Accounting for physiological status. J Crit Care. 2021;67:149-156doi: 10.1016/j.jcrc.2021.11.005.
Bedford, J. P., Johnson, A., Redfern, O., Gerry, S., Doidge, J., Harrison, D., Rajappan, K., Rowan, K., Young, J. D., Mouncey, P., & Watkinson, P. J. (2021). Comparative effectiveness of common treatments for new-onset atrial fibrillation within the ICU: Accounting for physiological status. Journal of critical care, 67149-156. https://doi.org/10.1016/j.jcrc.2021.11.005
Bedford, Jonathan P, et al. "Comparative effectiveness of common treatments for new-onset atrial fibrillation within the ICU: Accounting for physiological status." Journal of critical care vol. 67 (2021): 149-156. doi: https://doi.org/10.1016/j.jcrc.2021.11.005
Bedford JP, Johnson A, Redfern O, Gerry S, Doidge J, Harrison D, Rajappan K, Rowan K, Young JD, Mouncey P, Watkinson PJ. Comparative effectiveness of common treatments for new-onset atrial fibrillation within the ICU: Accounting for physiological status. J Crit Care. 2021 Nov 16;67:149-156. doi: 10.1016/j.jcrc.2021.11.005. Epub 2021 Nov 16. PMID: 34798373.
Copy Download .nbib Format: NLM
Pharmacological and non-pharmacological treatments and outcomes for new-onset atrial fibrillation in ICU patients: the CAFE scoping review and database analyses.

Health technology assessment (Winchester, England)

Bedford J, Drikite L, Corbett M, Doidge J, Ferrando-Vivas P, Johnson A, Rajappan K, Mouncey P, Harrison D, Young D, Rowan K, Watkinson P.
PMID: 34847987
Health Technol Assess. 2021 Nov;25(71):1-174. doi: 10.3310/hta25710.

BACKGROUND: New-onset atrial fibrillation occurs in around 10% of adults treated in an intensive care unit. New-onset atrial fibrillation may lead to cardiovascular instability and thromboembolism, and has been independently associated with increased length of hospital stay and mortality....

Cite
Bedford J, Drikite L, Corbett M, et al. Pharmacological and non-pharmacological treatments and outcomes for new-onset atrial fibrillation in ICU patients: the CAFE scoping review and database analyses. Health Technol Assess. 2021;25(71):1-174doi: 10.3310/hta25710.
Bedford, J., Drikite, L., Corbett, M., Doidge, J., Ferrando-Vivas, P., Johnson, A., Rajappan, K., Mouncey, P., Harrison, D., Young, D., Rowan, K., & Watkinson, P. (2021). Pharmacological and non-pharmacological treatments and outcomes for new-onset atrial fibrillation in ICU patients: the CAFE scoping review and database analyses. Health technology assessment (Winchester, England), 25(71), 1-174. https://doi.org/10.3310/hta25710
Bedford, Jonathan, et al. "Pharmacological and non-pharmacological treatments and outcomes for new-onset atrial fibrillation in ICU patients: the CAFE scoping review and database analyses." Health technology assessment (Winchester, England) vol. 25,71 (2021): 1-174. doi: https://doi.org/10.3310/hta25710
Bedford J, Drikite L, Corbett M, Doidge J, Ferrando-Vivas P, Johnson A, Rajappan K, Mouncey P, Harrison D, Young D, Rowan K, Watkinson P. Pharmacological and non-pharmacological treatments and outcomes for new-onset atrial fibrillation in ICU patients: the CAFE scoping review and database analyses. Health Technol Assess. 2021 Nov;25(71):1-174. doi: 10.3310/hta25710. PMID: 34847987.
Copy Download .nbib Format: NLM
Development of platforms for functional characterization and production of phenazines using a multi-chassis approach via CRAGE.

Metabolic engineering

Ke J, Zhao Z, Coates CR, Hadjithomas M, Kuftin A, Louie K, Weller D, Thomashow L, Mouncey NJ, Northen TR, Yoshikuni Y.
PMID: 34890798
Metab Eng. 2021 Dec 07; doi: 10.1016/j.ymben.2021.11.012. Epub 2021 Dec 07.

Phenazines (Phzs), a family of chemicals with a phenazine backbone, are secondary metabolites with diverse properties such as antibacterial, anti-fungal, or anticancer activity. The core derivatives of phenazine, phenazine-1-carboxylic acid (PCA) and phenazine-1,6-dicarboxylic acid (PDC), are themselves precursors for...

Cite
Ke J, Zhao Z, Coates CR, et al. Development of platforms for functional characterization and production of phenazines using a multi-chassis approach via CRAGE. Metab Eng. 2021;doi: 10.1016/j.ymben.2021.11.012.
Ke, J., Zhao, Z., Coates, C. R., Hadjithomas, M., Kuftin, A., Louie, K., Weller, D., Thomashow, L., Mouncey, N. J., Northen, T. R., & Yoshikuni, Y. (2021). Development of platforms for functional characterization and production of phenazines using a multi-chassis approach via CRAGE. Metabolic engineering, . https://doi.org/10.1016/j.ymben.2021.11.012
Ke, Jing, et al. "Development of platforms for functional characterization and production of phenazines using a multi-chassis approach via CRAGE." Metabolic engineering vol. (2021). doi: https://doi.org/10.1016/j.ymben.2021.11.012
Ke J, Zhao Z, Coates CR, Hadjithomas M, Kuftin A, Louie K, Weller D, Thomashow L, Mouncey NJ, Northen TR, Yoshikuni Y. Development of platforms for functional characterization and production of phenazines using a multi-chassis approach via CRAGE. Metab Eng. 2021 Dec 07; doi: 10.1016/j.ymben.2021.11.012. Epub 2021 Dec 07. PMID: 34890798.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 40 entries